July 19, 2012
/PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from
. This is the second year in a row that AMRI received the Silver Shield award in the category of "Strategic Partner," which recognizes AMRI's attention to communication, business continuity, quality, flexible pricing and in-time dispatches.
"This is a testimony of the quality of services that AMRI India offers and the confidence that our customers have in our services," said
, President of India Operations. "We are very proud to be receiving this award for the second year in a row. Our goal is to raise the bar and continue to provide the highest level of customer service to Abbott and all of our customers."
Abbott began this initiative in 2011 for its valued business partners in appreciation of their support during the past year. These awards recognize significant performance and outstanding support. Awards were given in the following three categories: Innovative Partner, Customer Centric Partner and Strategic Partner.
"This award underscores our commitment to our clients and the strength of our SMARTSOURCING™ strategy," said Thomas E. D'Ambra, Ph.D., Chairman, President and CEO of AMRI. "With the recent additions to our senior leadership team in
and the expansion of our capabilities, we are well positioned to continue to meet the future needs of our clients."
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in
the United States
now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
AMRI India Pvt. Ltd.
AMRI India Pvt. Ltd. features large-scale manufacturing facilities located in the city of Aurangabad,
. AMRI provides high quality manufacturing services for manufacturing generics, APIs and Intermediates. The technology transfer team at Aurangabad, comprising scientists and technologists, provide scale-up and manufacturing services from small scale to full scale commercial quantities.